We only have this paper's title and publication details.
Read it at the sourceMolecular profiling reveals aggressive and favorable cell states in chronic myelomonocytic leukemia, indicating RNA editing as a biomarker for disease prognosis.
No takes yet. Share an insight, caveat, or question.
Wickramasinghe et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: